Navigation Links
BioDelivery Sciences to Present at the Stifel Nicolaus 2013 Healthcare Conference
Date:9/6/2013

ct of 1995.  Such forward-looking statements involve significant risks and uncertainties.  Such statements may include, without limitation, statements with respect to the Company's plans, objectives, projections, expectations and intentions and other statements identified by words such as "projects," "may," "will," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "potential" or similar expressions.  These statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties, including those detailed in the Company's filings with the Securities and Exchange Commission and those that relate to the Company's ability to leverage the expertise of employees and partners to assist the Company in the execution of its strategy.  Actual results (including, without limitation, the timing for and results of the clinical trials and proposed NDA submissions for, and FDA review of, the Company's products in development) may differ significantly from those set forth in the forward-looking statements.  These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company's control).  The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. 

Readers are cautioned that peak sales and market size estimates have been determined on the basis of market research and comparable product analysis, but no assurances can be given that such estimates are accurate or that such sales levels will be achieved, if at all.

BDSI® and BEMA® are registered trademarks of BioDelivery Sciences International, Inc.  The BioDelivery Sciences logo and BUNAVAIL™
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Endo and BioDelivery Sciences Provide Update on BEMA Buprenorphine Phase III Development Program
2. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Second Quarter 2013 Financials
3. BioDelivery Sciences Announces Submission of NDA for BUNAVAIL
4. BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs
5. BioDelivery Sciences to Present at the William Blair 33rd Annual Growth Stock Conference
6. BioDelivery Sciences to Present at the Jefferies 2013 Global Healthcare Conference
7. BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
8. BioDelivery Sciences Appoints Thomas W. DAlonzo to Board of Directors
9. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2012 Annual Report
10. BioDelivery Sciences to Present at the 25th Annual ROTH Conference
11. BioDelivery Sciences to Host Buprenorphine Investor and Analyst Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 Cardinal Health today announced ... Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and ... THDG was owned by Court Square Capital Partners. The ... cash and new debt.  Headquartered in ... Group had revenues of approximately $450 million in 2014. ...
(Date:7/6/2015)... 29, 2015 Research and ... "Urinary Slings Market in the US 2015-2019" ... the Urinary Slings market in the US to grow ... 2014-2019. This report covers the present scenario and ... the US for the period 2015-2019. To calculate the ...
(Date:7/6/2015)... , June 29, 2015 ... addition of the "Pharmaceutical Grade Sodium Chloride Market ... to 2019" report to their offering. ... witness a CAGR of 6.9% between 2014 and 2019 ... to reach 690 KT by 2019. The ...
Breaking Medicine Technology:Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
... NASHVILLE, Tenn. , April 26 Cumberland Pharmaceuticals Inc. ... preference study evaluating Kristalose® ( lactulose ) for Oral Solution, a prescription ... Digestive Disease Week® meeting in New Orleans .   , ... A poster presentation of the study, ...
... DIEGO , April 26 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... of Neurocrine Biosciences, will be presenting at the Deutsche Bank 35th Annual Health ... , , ... 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time . ...
Cached Medicine Technology:Kristalose(R) Clinical Data to Be Presented at Digestive Disease Week(R) Meeting 2Kristalose(R) Clinical Data to Be Presented at Digestive Disease Week(R) Meeting 3Neurocrine Biosciences to Present at the Deutsche Bank 35th Annual Health Care Conference 2
(Date:7/6/2015)... ... July 06, 2015 , ... For over twenty years, ... personal injury victims. Throughout the company’s history the goal has been to be ... need in their recovery. And while Doctors on Liens has certainly achieved that ...
(Date:7/6/2015)... ... July 06, 2015 , ... PristineHydro ( http://www.pristinewaterfilters.com ) has ... and impurities; it also properly mineralizes the water with electrolyte salts.  Common tap ... harmful contaminants are a byproduct of how the water is treated chemically.  In ...
(Date:7/6/2015)... ... ... in a report titled “ Female Hair Loss Needs to be Talked About, Shed Stigma, ... in the U.S. will suffer from thinning hair or hair loss . For these 30 ... former beauty queen, who was interviewed for the report began losing her hair at age 11 ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... year for aesthetic reasons, which is why liposuction regularly ranks among the top ... however, fat reduction has become more than a way to slim down a ...
(Date:7/6/2015)... ... July 06, 2015 , ... doTERRA, the leading global essential oils ... team. Most recently, Jowers held the position as Director of the Hinckley Institute at ... a decade building the institute, Jowers states that he was ready for a new ...
Breaking Medicine News(10 mins):Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4
... partners and installations drive adoption of PLUS in Real-Time Location ... ... Ala., Jan. 28 Time Domain Corporation, (http://www.timedomain.com ), a ... announced the first eleven partners to its,global channel reseller network ...
... equivalent of 4 cups a day led to spikes in ... New research suggests the caffeine in those daily cups of ... a small group of 10 diabetics, glucose levels rose by ... of caffeine found in four cups of coffee. , "There,s ...
... articles abound in the,news, with many of them focused on ... people being under-treated, or those that suffer,from conditions like back ... to the Centers for Disease Control and Prevention (CDC),roughly 25 ... Estimates,put the number of people hurting at around 50 million. ...
... Bulletin,Board: NTRZ), a world leader in stabilized rice bran ... its domestic,operations., The Company stated that its Stage ... full capacity since the middle of the fourth,quarter and ... disassembled for,cleaning. Further, the facility is fully committed to ...
... Time -, SAN FRANCISCO, Jan. 28 Medivation, ... its end-of-Phase 2 meeting,with the U.S. Food and Drug ... Phase 3 trial of Dimebon(TM) for,mild-to-moderate Alzheimer,s Disease in ... Medivation that the company,s previously completed,trial conducted in Russia ...
... Insight into Pharmaceutical Information Use and ... Online Media ... in,syndicated research and marketing services for the health and,pharmaceutical industry, announced ... for subscribing clients.,This online study of U.S. consumers includes trended data ...
Cached Medicine News:Health News:Time Domain Adds Eleven Partners to its Channel Reseller Network of PLUS(TM) Ultra Wideband Solutions Providers 2Health News:Time Domain Adds Eleven Partners to its Channel Reseller Network of PLUS(TM) Ultra Wideband Solutions Providers 3Health News:Caffeine Could Spell Trouble for Diabetics 2Health News:What You Don't Know About Pain Management Could Hurt You 2Health News:NutraCea Provides Update on Domestic Operations 2Health News:NutraCea Provides Update on Domestic Operations 3Health News:Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimer's Disease in Second Quarter of 2008 2Health News:Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimer's Disease in Second Quarter of 2008 3Health News:Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available 2
... Medical is the world leader in ... used worldwide for permanent pacemaker and ... and port implantation, and for temporary ... St. Jude Medical Peel-Away introducers includes ...
... Self-Expanding Stent System combines low-profile, high radial force, ... guide wire compatible stent system provides 6F sheath ... (5.0 - 10.0 mm). Now, with longer stents ... five stent lengths (28, 38, 56, 80 and ...
... left heart catheterization occurs when the initial ... sheath with an alternate curve while maintaining ... exchange has required a repeat septal puncture--complex ... overcome this problem with the unique PERRY ...
Coaxial Multicolor LIO Worlds first coaxial multicolor LIO provides precise laser delivery with repeatable outcomes, as well as maximum treatment options and physician safety....
Medicine Products: